Atossa Therapeutics
ATOS
#9542
Rank
โ‚น6.68 B
Marketcap
โ‚น51.78
Share price
-5.83%
Change (1 day)
-28.78%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2025 (TTM): -โ‚น21.52

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น22.91. In 2024 the company made an earnings per share (EPS) of -โ‚น18.33 an increase over its 2023 EPS that were of -โ‚น21.99.

EPS history for Atossa Therapeutics from 2010 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น21.5217.42%
2024-โ‚น18.33-16.67%
2023-โ‚น21.9914.29%
2022-โ‚น19.2416.67%
2021-โ‚น16.50-90.86%
2020-โ‚น180.53-2.96%
2019-โ‚น186.03-63.09%
2018-โ‚น504.03-49.63%
2017-โ‚น1,001-57.87%
2016-โ‚น2,375-74.01%
2015-โ‚น9,138-9.18%
2014-โ‚น10,062-12.86%
2013-โ‚น11,54770.73%
2012-โ‚น6,76334.08%
2011-โ‚น5,044263.47%
2010-โ‚น1,388

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น956.68-4,275.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น791.78-3,556.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น939.32-4,200.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น80.64 252.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-โ‚น19.24-16.00%๐Ÿ‡บ๐Ÿ‡ธ USA